Albinda, Realyn T.
HRN: 22-00-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
CEFUROXIME 500MG (TAB)
10/01/2022
10/08/2022
ORAL
1 Cap
BID
SP NSVD + Periniorrhapy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes